A study of dermatological efficacy after continuous application of topical product (CDM050) in human skin
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2017
At a glance
- Drugs CDM 050 (Primary)
- Indications Skin disorders
- Focus Pharmacodynamics; Pharmacogenomic
- Sponsors Kao Corporation
- 04 Apr 2017 Status changed from recruiting to completed.
- 16 Feb 2017 Status changed from not yet recruiting to recruiting.
- 18 Jan 2017 New trial record